Biobank for Inflammatory Chronic Diseases and Osteoporosis

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Sep 6, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on creating a biobank, which is a collection of biological samples from patients with certain chronic conditions such as rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and osteoporosis. The goal is to study these samples to find markers that might help us understand how patients respond to different treatments. This information could be very valuable in improving care for people with these conditions.

To participate in this study, individuals must be between the ages of 65 and 159 and have been diagnosed with one of the chronic inflammatory diseases or osteoporosis. They also need to be able to agree to take part in the study and have health coverage. Unfortunately, those who are pregnant or breastfeeding, unable to provide consent, or have severe anemia (a condition where the blood has low levels of hemoglobin) cannot join. Participants will contribute samples, and in return, they will help advance research that could lead to better treatments for these diseases in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
• • With National Health Assurance
• • Able to consent to the study
• Exclusion Criteria:
• • Pregnancy or breastfeeding
• • Not able to give a consent
• • Severe anemia (Hb\<10g/L)